Your browser doesn't support javascript.
loading
Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.
Bonetto, Valentina; Pasetto, Laura; Lisi, Ilaria; Carbonara, Marco; Zangari, Rosalia; Ferrari, Erica; Punzi, Veronica; Luotti, Silvia; Bottino, Nicola; Biagianti, Bruno; Moglia, Cristina; Fuda, Giuseppe; Gualtierotti, Roberta; Blasi, Francesco; Canetta, Ciro; Montano, Nicola; Tettamanti, Mauro; Camera, Giorgia; Grimoldi, Maria; Negro, Giulia; Rifino, Nicola; Calvo, Andrea; Brambilla, Paolo; Biroli, Francesco; Bandera, Alessandra; Nobili, Alessandro; Stocchetti, Nino; Sessa, Maria; Zanier, Elisa R.
Afiliación
  • Bonetto V; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Pasetto L; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Lisi I; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Carbonara M; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Zangari R; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Ferrari E; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Punzi V; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Luotti S; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Bottino N; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Biagianti B; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Moglia C; "Rita Levi Montalcini", Department of Neuroscience, University of Turin, Turin, Italy.
  • Fuda G; AOU Città della Salute e della Scienza Hospital, Turin, Italy.
  • Gualtierotti R; "Rita Levi Montalcini", Department of Neuroscience, University of Turin, Turin, Italy.
  • Blasi F; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Canetta C; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Montano N; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Tettamanti M; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Camera G; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Grimoldi M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Negro G; Department of Neurology, Papa Giovanni XXIII Hospital, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Rifino N; Department of Neurology, Papa Giovanni XXIII Hospital, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Calvo A; Neurology Section, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Brambilla P; Division of Neurology, University of Milano-Bicocca, Milan, Italy.
  • Biroli F; "Rita Levi Montalcini", Department of Neuroscience, University of Turin, Turin, Italy.
  • Bandera A; AOU Città della Salute e della Scienza Hospital, Turin, Italy.
  • Nobili A; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Stocchetti N; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Sessa M; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Zanier ER; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Front Immunol ; 13: 1070379, 2022.
Article en En | MEDLINE | ID: mdl-36591311

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Amiotrófica Lateral / Enfermedades del Sistema Nervioso Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Amiotrófica Lateral / Enfermedades del Sistema Nervioso Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Italia